RNWBX
Price
$84.93
Change
-$0.11 (-0.13%)
Updated
Jul 18 closing price
Net Assets
70.21B
RNWCX
Price
$87.62
Change
-$0.11 (-0.13%)
Updated
Jul 18 closing price
Net Assets
70.21B
Interact to see
Advertisement

RNWBX vs RNWCX

Header iconRNWBX vs RNWCX Comparison
Open Charts RNWBX vs RNWCXBanner chart's image
American Funds New World R2
Price$84.93
Change-$0.11 (-0.13%)
VolumeN/A
Net Assets70.21B
American Funds New World R3
Price$87.62
Change-$0.11 (-0.13%)
VolumeN/A
Net Assets70.21B
RNWBX vs RNWCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RNWBX vs. RNWCX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWBX is a Buy and RNWCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX (70.2B) and RNWCX (70.2B) have equal amount of cash in the bank . RNWCX pays higher dividends than RNWBX: RNWCX (0.52) vs RNWBX (0.13). RNWBX was incepted earlier than RNWCX: RNWBX (23 years) vs RNWCX (23 years). RNWBX (1.67) is less costly to investors than RNWCX (1.22). RNWBX (37.00) and RNWCX (37.00) have comparable annual turnover. RNWBX (250) and RNWCX (250) have matching initial minimum investment requirements. RNWCX annual gain was more profitable for investors over the last year : 11.48 vs. RNWBX (10.89). RNWCX return over 5 years is better than : 26.93 vs. RNWBX (24.30).
RNWBXRNWCXRNWBX / RNWCX
Total Expense Ratio1.671.22137%
Annual Report Gross Expense Ratio1.671.22137%
Fund Existence23 years23 years-
Gain YTD15.47215.76298%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets70.2B70.2B100%
Annual Yield % from dividends0.130.5224%
Returns for 1 year10.8911.4895%
Returns for 3 years35.4736.8796%
Returns for 5 years24.3026.9390%
Returns for 10 years60.4664.2794%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESTC86.790.49
+0.57%
Elastic NV
ENTO0.47N/A
-0.08%
Entero Therapeutics Inc.
HTH31.29-0.06
-0.19%
Hilltop Holdings
XOS3.37-0.09
-2.60%
Xos
CGEM7.53-0.24
-3.09%
Cullinan Therapeutics